Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in BSX — Boston Scientific Corp

CIK 886982 NEW YORK, NY
Back to BSX Full portfolio

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$723,611,313
-$461,838,090 QoQ
Shares Held
16,954,342
-10.3% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#17
of 1,468 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 86% Shared 0% None 13%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Jun 30, 2026
CallValue
$89,773,112
CallShares
2,103,400
PutValue
$6,402,000
PutShares
150,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $6,794,178,953 across 97 Medical Devices names. BSX ranks #3 (10.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 16,760,070 $1,520,808,749
2 SYK
Stryker Corp
 2,783,782 $876,445,924
3 BSX
Boston Scientific Corp
This page 		16,954,342 $723,611,313
4 MDT
Medtronic plc
 9,012,210 $705,025,184
5 EW
Edwards Lifesciences Corp
 4,549,113 $411,512,760
6 STE
STERIS plc
 1,363,145 $287,037,441
7 GEHC
GE HealthCare Technologies Inc.
 4,446,565 $284,624,625
8 PEN
Penumbra Inc
 847,104 $267,473,087

All Filings in BSX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,402,000 150,000
2026-06-30 $89,773,112 2,103,400
2026-06-30 $723,611,313 16,954,342
2026-03-31 $1,185,449,403 18,891,624
2026-03-31 $29,806,250 475,000
2025-12-31 $1,580,799,733 16,578,917
2025-12-31 $5,148,900 54,000
2025-12-31 $15,208,325 159,500
2025-09-30 $41,395,120 424,000
2025-09-30 $15,571,985 159,500
2025-09-30 $1,464,963,432 15,005,259
2025-06-30 $5,800,140 54,000
2025-06-30 $1,496,756,305 13,934,981
2025-06-30 $17,668,945 164,500
2025-03-31 $5,447,520 54,000
2025-03-31 $16,090,360 159,500
2025-03-31 $1,405,241,449 13,929,832
2024-12-31 $1,150,915,707 12,885,308
2024-12-31 $4,823,280 54,000
2024-12-31 $16,032,940 179,500
2024-09-30 $13,366,100 159,500
2024-09-30 $1,109,724,598 13,242,537
2024-09-30 $4,525,200 54,000
2024-06-30 $1,034,152,578 13,428,809
2024-06-30 $9,664,755 125,500
2024-03-31 $1,004,506,389 14,666,468
2024-03-31 $9,588,600 140,000
2024-03-31 $18,101,907 264,300
2023-12-31 $8,839,149 152,900
2023-12-31 $17,649,393 305,300
2023-12-31 $926,491,557 16,026,493
2023-09-30 $877,448,243 16,618,338
2023-09-30 $13,200,000 250,000
2023-09-30 $12,144,000 230,000
2023-06-30 $13,522,500 250,000
2023-06-30 $1,015,335,017 18,771,215
2023-06-30 $8,784,216 162,400
2023-03-31 $894,234,016 17,873,956
2022-12-31 $3,113,971 67,300
2022-12-31 $831,033,672 17,960,529
2022-09-30 $836,568 21,600
2022-09-30 $753,881,346 19,465,049
2022-09-30 $573,204 14,800
2022-06-30 $536,766,636 14,402,110
2022-06-30 $2,549,268 68,400
2022-06-30 $1,125,554 30,200
2022-03-31 $2,373,944 53,600
2022-03-31 $1,922,186 43,400
2022-03-31 $790,374,978 17,845,450
2021-12-31 $805,255,592 18,956,111

Report a Problem

Category
Description
Email (optional, for follow-up)